Thursday, December 11, 2014

Akums Drugs & Pharmaceuticals voted as India’s Most technically & scientifically advanced Pharmaceutical Manufacturing Company of the year 2014 at Pharmaleaders Power Brand 2014

Akums Drugs & Pharmaceuticals voted as India’s Most technically & scientifically advanced Pharmaceutical Manufacturing Company of the year 2014 at Pharmaleaders Power Brand 2014
7th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2014 will felicitate Indian Drug Maker Akums Drugs & Pharmaceuticals For top Manufacturing Excellence & State of the Art Technology at the the 7th Annual Pharmaceutical Leadership Summit & Pharma Leaders™ Business Leadership Awards 2014. This Historic Summit is focusing in Make In India Campaign & is co - organized by Ministry of Health &  Family Affairs, Govt of India, Ministry of Pharmaceuticals , Government of india & host of other trade bodies. Unlike last year, this Summit is debating on two important Sessions. in a uniquely positioned full day program encompassing two themes “Make In India, Healthcare Reforms,  Insurance,Innovations,Investments & Infrastructure” & Empowering India’s Developing Healthcare System - Investing the Healthcare Solutions of Tomorrow in difficult Times on December,26th , 2014 at Hotel Sahara Star, Mumbai International Airport in Mumbai, India.
Pharma Leaders™ , asia’s biggest media in healthcare communications in association with Network 7 Media Group undertook the gigantic task of identifying the Leader in Healthcare Innovations as it has been doing for years. The Primary factor that propelled the Jury was to look at the forward looking vision of the company coupled with the risk taking abilities & the visionary Leadership of steering the company in the complex business of healthcare where each day we are witnessing new competition, bigger challenges & ability to stay ahead of competition.
internationally recognized WHO-GMP certified and one of the leading contract manufacturing and has rapidly emerged as the premier integrated pharmaceutical company with wide range of US-FDA norms producing HORMONAL preparations in Oral (Solid & Liquid) & Injectable forms, Skin Ointments & Cosmetic preparations, Oncology formulations and Contract Research and Manufacturing Services. As  one of the largest manufacturers and six state-of-the-art manufacturing facilities have huge per day capacity to produce formulations in practically all dosage forms, i.e. Tablets, Capsules, Soft Gels, Dry Syrups, Liquid Orals, Powder in Sachet, Dry & Liquid Injections, Pre-filled Syringes, Large Volume Parenterals (up to 100 ml) and Eye / Ear / Nasal Drops in Form Fill & Seal and Three Piece Packs. Akums  have  established a strong global footprint in fulfilling the requirements of clients across the Globe.  
Under the dynamic leadership of the visionary Chairman Mr.D.C.Jain with Mr Sanjeev Jain, Akums has been a biggest force in the Indian Pharma industry in contract manufacturing.

The Award ceremony is scheduled at 07.00 PM on 26th December 2014 onwards at the Grand Jade Room of Hotel sahara Star, Mumbai, India. Like every year, this will be attended by more than 300 power packed Healthcare Leaders in all disciple in the glittering award night followed by cocktail & Dinner.

Akums are India’s largest contract manufacturing company engaged in manufacturing of  pharmaceutical formulations, ayurvedic / herbal preparations, hormones, neutraceuticals and more. The growth path of AKUMS was laid down by its promoters Mr. Sanjeev Jain and Mr. Sandeep Jain under the guidance of Mr. D.C.Jain in the year 2004.Quality, innovation and customer satisfaction are virtues at Akums. The approach is technologically driven to serve the emerging needs in the ever expanding market. The 8 state of art facilities are dedicated to separate dosage forms across therapeutic segments. The infrastructure is equipped with sophisticated and modern equipment & Machines with huge per day manufacturing capacities in all section. Akums has an acumen to innovate, and dedication to provide quality products and a progressive learning attitude. In Akums continuous pursuit of Healthier today and tomorrow, Akums are working towards redesigning global healthcare.

Mission
To be a globally admired pharmaceutical company providing excellent quality products to Akums customers and people of the world.

Akums Vision
To be a global pharmaceutical company with an enduring commitment to quality.

Business Model

One stop solution for contract manufacturing services in all dosage forms .
Contract Research & Manufacturing Services (CRAMS),
Formulation & development of Novel Drugs Delivery Systems (N.D.D.S.),
Loan License,
New Formulations with DCGI Approvals,
Institutional business
Technology Transfer,
Technical collaboration and Joint venture,

Akums specializes in developing new formulations, undertaking bioequivalence studies, clinical trials, obtaining Drug Controller General of India's (DCGI) approval for manufacturing and marketing of new Fixed Dose Combinations (FDCs) & molecules and thereby offering new formulations with Akums’s own technology to its customers under their brand names. Akums manufactures innovative and technology driven products.

FEW SPECIALIZED PRODUCTS DEVELOPED

Akums are engaged in developing, manufacturing and supplying of products both in pharmaceuticals and nutraceuticals segment many of them for the First Time in India

1
Eno chewable Tablet & Suspension for GSK
2
Lemon Fizz Sachet for Dabur
3
Digene Fastmelt Mouth dissolving sachet for Abbott
4
Viscodyne Ayurvedic Cough Syrup for Wockhardt
5
Paracetamol 100 ml Infusion in FFS
6
Acceclofenac and Rabeprazole - Bi-Layered, Sustained Release Tablet in Tablet
7
Specially formulated colostrum cream for treatment in Acne as Akumsll as Acne Scars
8
Tablet in low RH like Cefopodoxime and Clavulanate
9
Lactitol and Isapaghula combination
10
Cefopodoxime and Ofloxacin Tablet
11
Progesterone Effervescent Tablets
12
Progesterone Vaginal Gel (In pre filled Applicator)
13
Sildenafil Jelly in Palatable Form
14
Oral Keratin with Multi Vitamins for Hair, Nail and Skin
15
Guaifenesin Vaginal Tablet
16
Sildenafil Vaginal Tablet
17
Jaundiff - Versatile Hepato Protector in Single Dose Remedy
18
Pinashin - Herbal solution to all Rhinological problems in single dose remedy
19
N- Acetylcysteine Effervescent Tablets
20
Metformin and Voglibose Tablet
21
Cefixime and Linezolid Tablet
22
Amoxycilin, Dicloxacilin and Lactic Acid Bacillus as Hard Gelatin Capsules
23
Trisodium Citrate Injection - Catheter Lock Solution
24
Alpha GPC and Piracetam Tablet
25
Sulbactum Injection
26
Calcium Citrate, Calcium Aspartate, Calcium Orotate, Milk Calcium and Vitamin D3 Tablet
27
Cefixime and Docloxacilin Tablet
28
Omeprazole and Domperidone Tablet
29
Rabeprazole and Zinc Carnosine Tablet
30
Diclofenac and Zinc Carnosine Tablet
31
AlliumCepa, Heparin Sodium and Allontoin Gel
32
Pamabrom and Paracetamol Tablet
33
Inlay Tablet
34
Cefuroxime Axetil and Cefpodoxime proxetil as Gastric Floating Tablets
35
Diclofenac 75 mg per 1 ml Injection
36
Enoxaparin Pre Filled Syringe
37
Caffeine Citrate Injection & Oral Solution
38
Ready to Use Antibiotic Syrups      
39
Bimatoprost eye drop for eye lashes



Breakthrough TECHNOLOGIES

Akums has always strived towards expanding its capabilities to develop breakthrough technologies. There is a constant endeavor to enhance and/or modify drug release profiles to maximize therapeutic value of the available formulations.

Out of the many, two breakthrough technologies are:
Fast Absol technology ®
In this technology, unique excipients are added to an oral dosage form for rapid disintegration. This technology enables quicker therapeutic effect with steady & stable release profiles .There is Great improvement in patient compliance

Do-Akumsll technology ®
This technology makes injectables less viscous, less painful and more efficacious. The patient compliance and doctor comfort in highly increased.


Akums cater to the following segments

Antibiotics
Cough & Cold Preparations
Anti Hypertensives
Antacids
Antiamoebics
Geriatric Care
Tranquilizers
Central Nervous System
Corticosteroids
Respiratory
Hormones
Gastrointestinal Tract (GIT)
Antiasthmatic
Urological
GenitAkumsinary
Gynaecology
Ophthalmic
Pediatrics
Pain Management
Cardiovascular
Dyslipidemia
Probiotics
Antipyretics
Dermatologicals
Antiepileptics
Cosmetics
Sedatives  / Hypnotics
Herbal Preparations
Antidiabetics / Diabetes Mellitus
Neutraceuticals
Antiemetics
Veterinary Preparations
Analgesics
Feed Supplement
Haematinics


AKUMS manufactures more than 2500 formulations in all dosage forms and therapeutic segments. GLOBAL PRESENCE
With manufacturing expertise along with innovation & quality approach, Akums has its presence marked in the Indian & global pharmaceutical space. Akums export Akums formulations to various global markets. Akums have filed substantial numbers of dossiers in different countries. The process of filing dossiers for regulated market is in advanced stage of progress. There is a full-fledged team of highly professional & experienced personnel competent to prepare and submit dossiers as per CTD, ACTD and guidelines of MOH of different countries.  Akums have a highly experienced team in international marketing to take the export to new heights. Akums have a progress plan laid and have plans to acquire USFDA approved facility to facilitate export to US and other regulated markets. The manufacturing units have International approvals like – ANVISA – Brazil; NAFDAC; Nigeria; FDB – Ghana; PMPB – Malawi; PPB – Kenya; MOH – Libya; MOH – Cambodia; DDA – Nepal; CD&DA – Sri Lanka; MOH – Vietnam; MOH – Belarus; DPM – Ivory Coast etc.Akums have Akums global foot prints in countries like Libya, Nigeria, Ghana, Ethiopia, Liberia,Malawi, Philippines, Vietnam, Hong kong, Sri-Lanka, Nepal, Bhutan, Myanmar, Afghanistan,Malaysia, Venezuela, Belarus, Ukraine, Tajikistan & Francophone countries etc. Akums has plans for registering and marketing its own brands in different countriesincluding regulatory countries,  through own staff. The endeavor is to export Akums uniqueformulations around the globe and redesign global Healthcare towards a happier world. 


















Recognitions

National Award for ‘Excellence in Product Quality’ and ‘Outstanding Entrepreneurship’
Best Emerging Companies Excellence Award and Best Corporate Governance Award by Business Today
India's most Admired Company in CRAMS Market
India's fastest growing Company in Contract Manufacturing
Business Leadership Award
Entrepreneur of the Year  for contribution in Corporate Social Responsibility
Quality brands India Award 2012 - 2014

Salient Features
  • The largest Pharmaceutical formulations manufacturer in India.
  • The Facilities are rated as one of the best                             
  • Manufacture 10% of India’s total domestic medicine consumption.
  • Manufacture more than 2500 formulations in various dosage forms.
  • Excise exemption benefits upto 2020
  • Manufacture number of top ORG brands.      
  • There would barely be any retail shops where products manufactured by us are not available
  • Offers formulations in almost all dosage forms across majority of therapeutic Segments.
  • Nearly 300 DCGI approvals received for New F.D.C.s and molecules & around 400are in pipeline.
  • Over 60 applications for Patent filed and many more in pipeline.
  • Constant Focus on Highest Quality standards under supervision of qualified & experienced personnel of the industry in QA, QC and production departments.


Follow Best policies for training & development of technical & Non-Technical Personnel.
Catering to GMSD, Indian Railways , Defence  ,ESIC, RMSCL, MSCL, DHS – Delhi, DHS Assam, DHS – Akumsst Bengal, ICDLWS, AIIMS – Delhi ,etc. Rated 5A2 by Dun & Bradstreet indicates overall status of the Company to be good.

A + (A Plus) and A 1 (A One) rating by ICRA for Long Term Rating and Short Term Rating.
Use integrated SAP and LIMS Software for operational excellence.
Manufacturing processes in all its units aim at ensuring maximum energy conservation,
pollution control and effective waste management.CSR activities are carried out intensively and throughout  the year.

Exports to Libya, Nigeria, Ghana, Ethopia, Liberia, Malawi, Philipines, Vietnam, Hong Kong, Sri Lanka, Nepal, Bhutan, Myanmar, Afghanistan, Malaysia, Venezuela, Belarus, Tajikistan & Francophone countries.
Akums has ultra modern infrastructure with around 200  packaging lines, 12 Alu-Alu, 2 AF 150, 1 AF 60, 18 Granulation section consisting of RMGs, 10 Fluid Bed Processors, 25 Auto-coaters, 2 FFS, 7 Tunnels, 550 AHU's

CENTRALIZED STABILITY STUDY FACILITIES
Akums Laboratories, duly approved by NABL are fully equipped for Physical and metallurgical testing, Micro-biological testing, Chemical testing, Pharmacological testing, Stability Studies etc.
Akums follow GLP Guideline as Good Laboratory Practices which embodies set of principles providing a framework within which laboratory studies are planned, performed, monitored, recorded, reported and archived.       
For assuring quality standards, Akums have Centralized Stability Study Chambers to conduct Stability Studies as per ICH Guidelines.
Akums have Large Stability Chambers comprising 1 Stability chamber with 100,000 capacity and 3 Stability Chambers with 2,00,000 capacity each. Stability for products is performed at various conditions by maintaining the environmental conditions as per regulatory requirement using number of AHUs, chillers, dehumidifiers etc.            

Laboratories equipped with latest instruments like TOCA (Total Organic Carbon Analyzer),

150 HPLC's, 3FTIR Spectrophotometers, Gas Chromatography Equipments.



PLANT- 1 TO 6
Plant photographs and Dosage manufacturing in each plant.

UPCOMING FACILITIES 
“Largest State-of-Art facilities
Pure & Cure Healthcare Ltd.
(Oral Solid Dosage Facility for General products / Non Beta Lactum)
Tablets, HG Capsules, Soft Gelatin Capsules, Powders, Bolus, Semi solids, Sachets.
Injectable block for general injections.
Malik Lifesciences Pvt. Ltd. has two separate buildings.
  • Cephalosporin Building for manufacturing Tablets, Capsules, Dry Syrups, Clavulanic  Formulations, Ready Mix etc.
  • Penicillin Building for manufacturing Tablets (Bi-layered, Sustained Release), Capsules (Hard / Soft Gelatin Capsules), Powders, Sachets, Low RH preparation, etc.
Inspiring Leadership



Shri D. C. Jain, B. Com., LL.B., M.I.L (Hons)., G.D.I.M., M.I.I.A., A.M.I.B.M. F.A.S.M., F.C.S., is a promoter of Akums Drugs & Pharmaceuticals Ltd. He has nearly five decades experience in controlling various industries as top level Company Executive. He had been President of the Institute of Company Secretaries of India. He is a professional of high stature. Under his stewardship, Akums Drugs & Pharmaceuticals Ltd., has become icon of India’s healthcare industry and today is the largest Pharmaceutical Company of India. It manufactures 10% of total Pharmaceutical formulations of the Country. Akums manufactures TOP 70 out of 100 ORGs brands.There is hardly any retail store in the country, where products manufactured by AKUMS are not available. Under leadership of Shri D.C Jain, the Company made several national and foreign collaboration agreements and reached new heights of growth. His innovative ideas in creation & retention of customers have brought company to its pinnacle.
Mr.Sanjeev Jain, a Promoter Director of the company, has 30 years of experience in the field of sales and marketing of pharmaceuticals. Shri Sanjeev Jain has been awarded order of Merit in Management and has also been honored as Samaj Shree for the kind voluntary services rendered by him to public & society. Udyog Ratan Awardee from Institute of Economics Studies, Business Partner of Choice by Piramal, commendable appreciation by Abbott India for the contribution extended in  launching Heptral first time in India. With his able leadership & vision, he has achieved the Best contract Manufacturer of the Year-2012 Award. The pharmaceutical industry identifies him as a visionary, leader & mentor who has achieved many milestones envisioning a future; while treating each milestone as a ladder to reach for more.Shri Sanjeev Jain has been instrumental in setting up the Company. He combines in himself dynamism, dedication, diligence, devotion, determination, discipline & direction. Under his wisdom, leadership and professional approach, the Company made several national and foreign collaboration agreements and reached new heights of growth. His innovative ideas in new product development, patents; creation & retention of customers have brought company to its pinnacle.  




Monday, December 8, 2014

Pharmaleaders Visionary Pharma Entrepreneur 2014 Awardee Dilip Surana led Microlabs aims $1 billion mark by 2016


Pharmaleaders Visionary Pharma Entrepreneur 2014 Awardee Dilip Surana led  Microlabs  aims $1 billion mark by 2016

Bangalore based Top Pharma Major Microlabs known as Dolo Maker plans to scale new heights under Dilip Surana’s Visionary & Commanding Leadership, Dilip Surana to receive “Visionary Entrepreneur of the Year Award” at Pharma Leaders 2014 Historic Meet


  
It is widely believed that the consolidations in the Indian pharma sector is likely to continue, particularly among generic drug players and will drive shareholder value going forward.India-based pharmaceutical companies have majorly been absent from much of the recent M&A activities, partly because of their healthy growth outlooks. The global pharmaceutical industry will continue to undergo a pace of rapid consolidation to drive shareholder value; particularly in the case of companies seeking new growth platforms, against the backdrop of patent expirations.With many drugs going off patent in the US, Indian pharma companies would continue to experience strong growth in American market, indian pharma companies would continue to experience strong growth in the US over the medium-term. This would be driven by the sizable generic opportunity (drugs with brand value of $25-30 billion are expected to face generic competition) over the next 2-3 years.

As one of the recently industrialized nations, India has a fast-growing economy as well as an ever-expanding, ever-urbanized population, however its healthcare system still has a lot of potential for development. To Western readers, analyzing a healthcare system in the East seems daunting. It takes some of us decades to master an understanding of the healthcare system of our origin country. Nevertheless, there are several methods to approaching another country’s system. These include the exposition of some invariant principles that apply across various contexts, the application of existing frameworks for healthcare system analysis, appraisal of the major transitions underway in the country, and an analysis of the country’s public health issues. India faces challenges in pursuing each of these goals. With regards to cost, at least 70% of all healthcare is frequently financed out-of-pocket by the population. There is little health insurance or other forms of risk pooling, little regulation and accountability of providers, and a predominance of fee-for-service payment, all of which are associated with high costs. There is also questionable efficiency of much of the state healthcare system, and a great distrust of the public sector. Against the backdrop of the above challenges, Pharmaleaders has lined up top industry experts, Pharma Academia, Ministry Officials, Government Representative, Policy Makers & Medical Professionals under one platform both in india & abroad to debate & deliberate the complex issues of the industry & give a meaningful discussion on the Brand India & Make In India concept. More than 300 professionals will be participating the mega event where professionals from Middle East, Africa, Europe, Lation America will also be attending.The historic 7th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2014 to be held in a uniquely positioned full day program encompassing two themes “Make In India – Healthcare Reforms , Insurance,Innovations,Investments & Infrastructure” & Empowering India’s Developing Healthcare System - Investing the Healthcare Solutions of Tomorrow in difficult Times at the Sahara Star, Mumbai International Airport in Mumbai, India, on December,26th , 2014. This  historic Summit is supported by the Government of India at the Centre & is actively supported  by the Ministry of Health &  Family Affairs, Govt of India, Ministry of Commerce Pharmaceuticals , Government of india & host of other trade bodies.

Commenting on the Award Selection to Dilip Surana as “Visionary Entrepreneur of the Year Award” at pharmaleaders 7th Award Night, Satya Brahma, Chairman & Editor-In-Chief of Network 7 Media Group said  “Pharma Leaders™ , asia’s biggest media in healthcare communications in association with Network 7 Media Group undertook the gigantic task of identifying the Leader in Healthcare Innovations as it has been doing for years. The Primary factor that propelled the Jury is to look at the forward looking vision of the company coupled with the risk taking abilities & the visionary Leadership of steering the company in the complex business of healthcare where each day we are witnessing new competition, bigger challenges & ability to stay ahead of competition. With a modest beginning as a pharmaceutical distributor in 1973 by Dilip Surana’s late father Shri G.C.Surana, the meteoric rise of Microlabs as a Leading player in pharmaceutical business with a formidable basket of top products enjoying the strong patronage of medical doctors can be attributed to the fact that how Dilip spearheaded the strategy to make it big. Today Microlab  is ranked among the top 20 pharma companies in the country.Indeed Microlabs has become one of the top 5 pharma players in the diabetes sector in India. Hailing from a village near Jodhpur in Rajasthan, the low profile Dilip Surana together with brother Anand Surana have propelled the growth engine with tremendous speed & dedicated mindset & your initiatives in the social sector is also a case to reckon with as Dilip’s efforts to help the marginalized sections of the society is a sign of a true global Leader. Pharma Leaders™ salute the deep commitment to bring cheers in the humanity & the visionary commanding Leadership in taking Microlabs to the crescendo of success & achievements”.

The Award ceremony is scheduled at 07.00 PM on 26th December 2014 onwards at the Grand Jade Room of Hotel sahara Star, Mumbai, India. Like every year, this will be attended by more than 300 power packed Healthcare Leaders in all disciple in the glittering award night followed by cocktail & Dinner

Mr. Dilip Surana son of Late Shri G. C. Surana (Founder of Micro Labs Limited) joined the family business in 1985 at a young age of 21 years, and  rapidly absorbed the nuances of Corporate Management that grew the company rapidly into a global pharmaceutical enterprise specializing in life saving medicinesHis early years in industry were marked by distinguished accomplishments and thus steering Micro Labs among the top ranking companies in the pharma sector. The AWACS ranking for the company has improved from over 100 in 1985 to 18 as on 2014. 

Under his leadership, the company established world-class state-of-the-art research and manufacturing facilities covering Active Pharmaceutical Ingredients (APIs) and finished dosage forms as well as infrastructure for new drug discovery. He instilled the most stringent quality standards in his pharmaceutical enterprise. As a result, Micro Labs has to its credit, all the international regulatory approvals including US FDA, UK MHRA, Australian TGA etc., reflecting the high standards of quality and regulatory compliance of research and manufacturing facilities.

Dilip Surana  pioneered the concept of specialty – wise focused divisions in the Indian Pharmaceutical Industry and established various divisions that cater to special therapeutic segments in chronic disease management.

Ø  Carsyon – Cardicare specialty division in 1994
Ø  Synapse – Neurology Psychiatry division in 1995
Ø  Vision – Ophthalmology division in 1998
Ø  Gratia – Dermatology Division in 1998
Ø  Diabetic Task Force Diabetology division in 2005
Ø  Foresee – Nephrology Division in 2008
Ø  Micro Critical Care - Critical Care Division 2013
He is a regular participant in various international seminars and summits relating to Pharma industry. He is instrumental in inducting Senior Pharma veterans in the company, to bring in the much needed professionalism in the company. Recognizing the dynamism and contribution of Mr. Dilip Surana to the Pharmaceutical Industry, he has been honored as the ‘Dynamic Entrepreneur of the year 2010’, honoured as the ‘Great Son of karnataka’ by Governor of Karnataka his excellency HR Bhardwaj in 2011, honoured as ‘Most Dynamic Entrepreneur of the Year’ 2013 and ‘Entrepreneur of the year’ 2014.  
Micro Labs Limited is a multi-faceted healthcare organization with a proficient marketing team, state-of-the-art manufacturing facilities and R&D centres that are at par with international standards. All this, robustly backed by a strong distribution network and path-breaking research work has placed us amongst India’s fast growing transnational healthcare organizations. Under the able leadership of Mr. Dilip Surana (Chairman & Managing Director) and Mr. Anand Surana (Director), Micro’s brand portfolio includes some of the topmost brands in various specialties like Cardiology, Diabetology, Anti-infectives, Ophthalmology, Pain, etc. Amidst our proud achievers is Dolo, an award-winning brand highly prescribed for fever management. Micro Labs has been ranked among top 17 (as per SMSRC July-Aug’14) in prescriptions and 19 in sales (as per AWACS Sept’14) in India. The group has its presence in over 30 countries, with ground level operations in 15 countries, exporting all major dosages in every therapeutic segment. Being one of the leading Indian healthcare providers in India, Micro Labs aims to be a prominent pharmaceutical player in regulated and non-regulated markets across the globe.The company is also at the forefront in social contribution, striving to be a model corporate citizen in terms of Environmental Protection & Social Initiatives with significant contributions in the areas of education and health.Micro Labs is poised to achieve unparalleled status in the global pharmaceutical industry. Backed by a profound and resolute vision, we now have our eyes set on attaining the $1 billion mark by 2016.

Pharmaleaders is  India’s first opinion based & research driven bi-monthly magazine & has a decade of relentless reporting in Pharma Journalism in an unbiased, fearless & independent way. Over the last one decade, The Magazine has covered some of the biggest voices in healthcare Industry. Available both in digital & printed format, Pharmaleaders has emerged out as a leading title in voicing the opinion of the healthcare industry to the statutory Authorities like Ministry of Health & Family Affairs, Dept of Chemicals & Fertilizers, DCGA, FDA & many other institutions to present the pressing demands of the healthcare industry. Network 7 Media Group Media Outfit, a unit of Pharmaleaders, is a result of emergence of an extreme thought process in the form of some of the biggest & exclusive media properties that arose due to the frustration & disappointment of the present status-quo of the society in existence in the form of a careless & extremely insensitive administration of a large set-up. Network 7 Group has continuously strived to expose the misdeeds of the corrupt administrative fabrics or poor legislation or failure of a large entity in corporate governanance. Distinctively standing out of other media initiatives, Network 7 group has been in the forefront of championing the cause of good governance , fair, unbiased & independent reporting in national & international fields. Driven by the objective to address & deliberate some of the burning issues, sometimes neglected causes, Pharmaleaders is pioneering the concept of introducing a fierce democratic process in the form a mass resistance in bringing into the forefront of issues that matter most in the form of digital, printed, published, conclaves, summits & even in blogs & letters shoot out to the authoritative.  Headquartered in Mumbai, Network 7 Group Media Outfit is backed & operated by some of the biggest think-tanks of the contemporary society whose ideas & actions are reflected in the form of editorials & exclusive news findings. Network 7 Group Media is present in the form of digital media production, publications, high-profile international events & healthcare communications
Media Contacts
Unit No.47, 2nd Floor, Aditya Industrial Estate,
CTS No. 1068-C, Plot No. 444(P),
Devrukhkar Wadi,Chincholi Bunder Road, Malad (W),
Mumbai–400064.+ 91 22 42481253, + 91 22 42481259
Mr Anish Khan : ++ 91 9819499475 : Anish@dreamzimc.com
Ms Sneha : ++ 91 9930583326  Sneha@dreamzimc.com  
news@pharmaleaders2014.in   Web : www.pharmaleaders2014.in